Copyright
©The Author(s) 2022.
World J Gastroenterol. Sep 7, 2022; 28(33): 4773-4786
Published online Sep 7, 2022. doi: 10.3748/wjg.v28.i33.4773
Published online Sep 7, 2022. doi: 10.3748/wjg.v28.i33.4773
Table 1 Current recommendations and potential indications for albumin administration in cirrhosis
| Current recommendations1 | Potential indications |
| Large-volume paracentesis | Modest-volume paracentesis |
| Acute kidney injury | Extraperitoneal infections |
| Hepatorenal syndrome | Long-term albumin administration in cirrhosis with ascites |
| Spontaneous bacterial peritonitis | |
| Decompensated cirrhosis with hypoalbuminemia | |
| Hepatic encephalopathy | |
| Hyponatremia | |
| Cirrhotic cardiomyopathy | |
| Acute-on-chronic liver failure |
- Citation: de Mattos ÂZ, Simonetto DA, Terra C, Farias AQ, Bittencourt PL, Pase THS, Toazza MR, de Mattos AA, Alliance of Brazilian Centers for Cirrhosis Care – the ABC Group. Albumin administration in patients with cirrhosis: Current role and novel perspectives. World J Gastroenterol 2022; 28(33): 4773-4786
- URL: https://www.wjgnet.com/1007-9327/full/v28/i33/4773.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i33.4773
